Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Pluristem Therapeutics Company Profile (NASDAQ:PSTI)

Consensus Ratings for Pluristem Therapeutics (NASDAQ:PSTI) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.83 (101.15% upside)

Analysts' Ratings History for Pluristem Therapeutics (NASDAQ:PSTI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/7/2014Jefferies GroupBoost Price Target$3.00 -> $3.50ViewTweet This Rating  Share This Rating on StockTwits
1/21/2014MLV & Co Boost Price TargetBuy$4.50 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2013Maxim GroupUpgradeHold -> Buy$8.00ViewTweet This Rating  Share This Rating on StockTwits
6/5/2013Jefferies GroupLower Price TargetHold$3.50 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
6/4/2013Maxim GroupDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
5/31/2013MLV & Co Initiated CoverageBuy$4.50ViewTweet This Rating  Share This Rating on StockTwits
3/18/2013Jefferies GroupInitiated CoverageHold$3.50ViewTweet This Rating  Share This Rating on StockTwits
7/25/2012Maxim GroupInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)